Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $36,144 | 6 | 99.5% |
| Travel and Lodging | $165.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sumitomo Pharma America, Inc. | $12,375 | 1 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $8,607 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $7,965 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $7,363 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,965 | 2 | GlaxoSmithKline, LLC. ($7,965) |
| 2023 | $12,375 | 1 | Sumitomo Pharma America, Inc. ($12,375) |
| 2022 | $8,607 | 3 | AMAG Pharmaceuticals, Inc. ($8,607) |
| 2021 | $7,363 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($7,363) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $7,800.00 | General |
| 10/23/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $165.00 | General |
| 04/27/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $12,375.00 | General |
| Category: Urology | ||||||
| 08/24/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 08/24/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $389.68 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 08/24/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $217.00 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 07/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $7,362.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 21 | $6,279 | $2,075 |
| 2022 | 1 | 16 | 31 | $5,766 | $2,658 |
| 2021 | 1 | 20 | 41 | $7,591 | $3,578 |
| 2020 | 3 | 47 | 65 | $13,323 | $6,826 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $6,279 | $2,075 | 33.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 31 | $5,766 | $2,658 | 46.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 41 | $7,591 | $3,578 | 47.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $5,475 | $2,954 | 54.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 33 | $5,848 | $2,942 | 50.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 15 | $2,000 | $930.25 | 46.5% |
About Dr. Vincent Lore, MD
Dr. Vincent Lore, MD is a Infectious Disease healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154357853.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Lore, MD has received a total of $36,309 in payments from pharmaceutical and medical device companies, with $7,965 received in 2024. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($36,144).
As a Medicare-enrolled provider, Lore has provided services to 94 Medicare beneficiaries, totaling 158 services with total Medicare billing of $15,137. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Philadelphia, PA
- Active Since 06/24/2006
- Last Updated 08/24/2011
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1154357853
Products in Payments
- GEMTESA (Drug) $12,375
- MAKENA (Drug) $8,607
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Philadelphia
Judith Wolf, Md, MD
Infectious Disease — Payments: $1.4M
Karam Mounzer, Md, MD
Infectious Disease — Payments: $802,727
William Short, Md, MD
Infectious Disease — Payments: $514,722
Pablo Tebas, Md, MD
Infectious Disease — Payments: $227,362
Ian Frank, Md, MD
Infectious Disease — Payments: $152,592
Lisa Spacek, M.d, M.D
Infectious Disease — Payments: $100,519